# Hacettepe University Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/hacettepe-university-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 41.8 |
| Citations | 242,707 |
| City | Ankara |
| Country | TR |
| Description | Hacettepe University Hospital is a research organisation in Ankara, TR. OpenAlex records 4,422 works and 242,707 citations for it. 969 researchers list it as their most recent affiliation. |
| Homepage | http://www.hastane.hacettepe.edu.tr/index_en.php |
| OpenAlex ID | https://openalex.org/I4210115551 |
| Researchers | 969 |
| ROR ID | https://ror.org/024q5j973 |
| Type | healthcare |
| Works | 4,422 |

## University papers

Showing 12 of 52.

- [2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides](https://scholariq.org/papers/2012-revised-international-chapel-hill-consensus-conference-nomenclature-of/)
- [The global threat of antimicrobial resistance: science for intervention](https://scholariq.org/papers/the-global-threat-of-antimicrobial-resistance-science-for-intervention/)
- [European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)](https://scholariq.org/papers/european-society-of-clinical-microbiology-and-infectious-diseases-escmid/)
- [Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2](https://scholariq.org/papers/early-onset-stroke-and-vasculopathy-associated-with-mutations-in-ada2/)
- [Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe](https://scholariq.org/papers/rapid-evolution-and-spread-of-carbapenemases-among-enterobacteriaceae-in-europe/)
- [2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative](https://scholariq.org/papers/2016-classification-criteria-for-macrophage-activation-syndrome-complicating/)
- [Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference](https://scholariq.org/papers/atypical-hemolytic-uremic-syndrome-and-c3-glomerulopathy-conclusions-from-a/)
- [Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease](https://scholariq.org/papers/loss-of-function-mutations-in-tnfaip3-leading-to-a20-haploinsufficiency-cause-an/)
- [Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study](https://scholariq.org/papers/effect-of-appropriate-combination-therapy-on-mortality-of-patients-with/)
- [2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis](https://scholariq.org/papers/2016-classification-criteria-for-macrophage-activation-syndrome-complicating-2/)
- [End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?](https://scholariq.org/papers/end-stage-renal-disease-atherosclerosis-and-cardiovascular-mortality-is-c/)
- [Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003](https://scholariq.org/papers/prevalence-awareness-treatment-and-control-of-hypertension-in-turkey-the-patent/)

## University researchers

- [Mustafa Arıcı](https://scholariq.org/researchers/mustafa-ar-c/)
- [Özge Soyer](https://scholariq.org/researchers/ozge-soyer/)
- [Bülent Enis Şekerel](https://scholariq.org/researchers/bulent-enis-sekerel/)
- [Alp Kazancıoğlu](https://scholariq.org/researchers/alp-kazanc-oglu/)

## University top topics

Showing 8 of 25.

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Muscle Physiology and Disorders](https://scholariq.org/topics/muscle-physiology-and-disorders/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.